摘要
目的探讨应用支气管动脉化疗联合氩等离子体治疗晚期中央型肺癌的近期疗效。方法分析比较我院45例晚期中央型肺癌分别行支气管动脉化疗+栓塞与支气管动脉化疗联合氩等离子体治疗疗效差别。结果支气管动脉化疗联合氩等离子体治疗晚期中央型肺癌组实体瘤缓解率(87.5%)及气道狭窄再通改善率(91.7%)明显优于支气管动脉化疗+栓塞组的57.1%及52.4%,且近期生存质量好。结论应用支气管动脉化疗联合氩等离子体治疗晚期中央型肺癌近期疗效明显优于支气管动脉化疗+栓塞治疗组,且能提高患者生活质量。
Objective To study the therapeutic effects to combine bronchial arterial chemotherapy with argon plasma coagulation on patients with advanced central type lung cancer. Methods 45 cases with central type lung cancer were collected, including one group treated by bronchial arterial chemotherapy combined with embolization and another group treated by bronchial arterial chemotherapy com- bined with argon plasma coagulation （APC）. Results The solid tumor response rate and airway narrowing recanalization rate of improve- ment in the group treated by bronchial arterial chemotherapy combined with argon plasma coagulation were respectively 87.5% and 91.7%, which were significantly higher than the group treated by bronchial arterial chemotherapy combined with embolization, respective- ly 57. 1% and 52.4%. At the same time, the patients treated by bronchial arterial chemotherapy combined with argon plasma coagulation enjoyed better quality of life recently. Conclusion The clinical therapeutic effects of bronchial arterial chemotherapy combined with argon plasma coagulation on patients with advanced stage central type lung cancer is apparently superior comparing with that of bronchial arterial chemotherapy and embolization treatment group. The combined therapy of arterial infusion and APC can improve patients＇life quality, thus it is worth being promoted clinically.
出处
《临床肺科杂志》
2013年第3期418-420,共3页
Journal of Clinical Pulmonary Medicine
关键词
支气管动脉化疗
栓塞
氩等离子体
中央型肺癌
bronchial arterial chemotherapy
embolization
argon plasma coagulation
central type lung cancer
